C12H19NO4
241.28 g/mol
의약 중간체위험
(1R,3S,4S)-2-(tert-butoxycarbonyl)-2-azabicyclo[2.2.1]heptane-3-carboxylic acid
CAS291775-59-2EC625-288-0
용도 분류
의약 중간체
화합물 분류
헤테로사이클
주요 용도
의약 중간체
This compound is a pharmaceutical intermediate specifically used in the manufacturing of ledipasvir. It is a protected amino acid derivative featuring a bicyclic azabicycloheptane core.
Pharmaceutical intermediate for ledipasvirBuilding block in organic synthesis
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 291775-59-2
관련 화합물
용도 관련동일 용도
(1R,3S,4S)-tert-butyl 3-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate
CAS1256387-87-7
Pharmaceutical intermediate for ledipasvir
용도 관련동일 용도
Ledipasvir Intermediate
CAS1256393-27-7
Pharmaceutical intermediate for ledipasvir
참고동일 카테고리
N-(2-((2-(Dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)-N-(3-((2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)amino)-3-oxopropyl)acrylamide
CAS2919324-18-6
research compound
참고동일 카테고리
4-CYANOBIPHENYL
CAS2920-38-9
Pharmaceutical intermediate synthesis
참고동일 카테고리
2'-Deoxyadenosine 5'-monophosphate sodium
CAS2922-74-9
pharmaceutical intermediate
참고동일 카테고리
DMTr-2'-O-C22-rU-3'-CE-Phosphoramidite
CAS2923115-86-8
Modified uridine phosphoramidite for oligonucleotide synthesis
안전 참조
위험
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
H360May damage fertility or the unborn child
H400Very toxic to aquatic life
식별자
IUPAC 이름
(1R,3S,4S)-2-[(2-methylpropan-2-yl)oxycarbonyl]-2-azabicyclo[2.2.1]heptane-3-carboxylic acid
InChIKey
IFAMSTPTNRJBRG-YIZRAAEISA-N
SMILES
CC(C)(C)OC(=O)N1[C@@H]2CC[C@@H](C2)[C@H]1C(=O)O
동의어 목록 (13)
- starbld0023488